SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
48 hedge funds and large institutions have $47.9M invested in Syros Pharmaceuticals, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
-5
Holders Change %
-9.43%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
13
Reduced
8
Closed
6
Calls
$1.04M
Puts
–
Net Calls
+$1.04M
Net Calls Change
+$212K
Top Buyers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
$3.27M |
| 2 |
CA
CHI Advisors
New York
|
$5.12M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
$6.25M |
| 4 |
BlackRock
New York
|
$971K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$2.09M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Dimensional Fund Advisors
Austin,
Texas
| – | -$37.8K | -12,015 | Closed |
|
|
CWM
52
CarsonAllaria Wealth Management
Glen Carbon,
Illinois
| – | -$328 | -104 | Closed |
|
|
S
53
SignatureFD
Atlanta,
Georgia
| – | -$274 | -87 | Closed |
|